Among the subtypes of inflammatory CNS disease are granulomatous meningoencephalitis, necrotizing meningoencephalitis, necrotizing leukoencephalitis, and eosinophilic meningoencephalitis, referred to as GME, NME, NLE, and EME, respectively. GME has been reported to affect the spinal cord and cause a subsequent meningomyelitis. Steroid-responsive meningitis-arteritis (SRMA) is another suspected autoimmune disorder that affects primarily the spinal cord; this disorder is not considered here. As a group, these diseases often are referred to as meningoencephalitis of unknown cause because antemortem diagnosis is difficult to achieve in most cases. Given the increasing availability of less invasive stereotactic brain biopsy instruments guided by magnetic resonance imaging (MRI) or computed tomography (CT), we anticipate that definitive diagnoses will become more attainable in the near future.
The disorders NME and NLE sometimes are referred to as pug dog encephalitis and Yorkshire terrier encephalitis, respectively. It is important to realize that dogs of many other breeds can develop NME and NLE and that these disorders are not exclusive to pug and Yorkshire terrier breeds. The author also has diagnosed GME in pug dogs and Yorkshire terriers and therefore advises against using this breed-specific terminology. Furthermore, the majority of the literature contains reports of noninfectious meningoencephalitis (NIME) in small-breed dogs; however, the author has definitively diagnosed GME in several large-breed retriever dogs.
To date, a definitive cause of granulomatous, necrotizing, and eosinophilic meningoencephalitides has not been established. Genetic, infectious, and autoimmune causes have been proposed. A recent study by Barber et al (2010) evaluating the results of polymerase chain reaction testing of brain tissue and cerebrospinal fluid (CSF) demonstrated that Ehrlichia, Anaplasma, Rickettsia, and Borrelia are unlikely to be associated with NIME; however, the role of Bartonella still is uncertain. It is the author’s belief that GME, NME, NLE, and EME are autoimmune in origin, and this constitutes the basis for our therapeutic approach. An underlying genetic predisposition for these diseases also may play a role.